18F-FDG PET/CT reveals disease remission in a patient with ipilimumab-refractory advanced melanoma treated with pembrolizumab
Pembrolizumab is an anti-programmed cell death receptor 1 (anti-PD-1) antibody, recently approved for the treatment of ipilimumab-refractory metastatic melanoma. We report on a 49-year-old patient with unresectable metastatic melanoma initially treated with 4 cycles of ipilimumab. Because of demonst...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
February 2016
|
| In: |
Clinical nuclear medicine
Year: 2016, Jahrgang: 41, Heft: 2, Pages: 156-158 |
| ISSN: | 1536-0229 |
| DOI: | 10.1097/RLU.0000000000001039 |
| Online-Zugang: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1097/RLU.0000000000001039 Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/nuclearmed/fulltext/2016/02000/18F_FDG_PET_CT_Reveals_Disease_Remission_in_a.13.aspx 
|
| Verfasserangaben: | Christos Sachpekidis, Jessica C. Hassel, and Antonia Dimitrakopoulou-Strauss |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 169765889X | ||
| 003 | DE-627 | ||
| 005 | 20230427190242.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200507s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/RLU.0000000000001039 |2 doi | |
| 035 | |a (DE-627)169765889X | ||
| 035 | |a (DE-599)KXP169765889X | ||
| 035 | |a (OCoLC)1341319200 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Sachpekidis, Christos |d 1983- |e VerfasserIn |0 (DE-588)1099707269 |0 (DE-627)858738651 |0 (DE-576)469338482 |4 aut | |
| 245 | 1 | 0 | |a 18F-FDG PET/CT reveals disease remission in a patient with ipilimumab-refractory advanced melanoma treated with pembrolizumab |c Christos Sachpekidis, Jessica C. Hassel, and Antonia Dimitrakopoulou-Strauss |
| 264 | 1 | |c February 2016 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 07.05.2020 | ||
| 520 | |a Pembrolizumab is an anti-programmed cell death receptor 1 (anti-PD-1) antibody, recently approved for the treatment of ipilimumab-refractory metastatic melanoma. We report on a 49-year-old patient with unresectable metastatic melanoma initially treated with 4 cycles of ipilimumab. Because of demonstration of progressive disease on PET/CT, the patient was enrolled into a clinical trial of pembrolizumab. After completion of 4 cycles of pembrolizumab, the follow-up PET/CT scans performed early after and 7 months after the end of treatment exhibited complete disease remission, reflecting the potential role of the modality in treatment response evaluation of melanoma patients receiving anti-PD-1 therapy. | ||
| 700 | 1 | |a Hassel, Jessica C. |d 1975- |e VerfasserIn |0 (DE-588)129790702 |0 (DE-627)480399069 |0 (DE-576)29783715X |4 aut | |
| 700 | 1 | |a Dimitrakopoulou-Strauss, Antonia |d 1963- |e VerfasserIn |0 (DE-588)1076688373 |0 (DE-627)835256901 |0 (DE-576)167486055 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical nuclear medicine |d Philadelphia, Pa. : Lippincott Williams & Wilkins, 1976 |g 41(2016), 2, Seite 156-158 |h Online-Ressource |w (DE-627)328186082 |w (DE-600)2045053-9 |w (DE-576)10318953X |x 1536-0229 |7 nnas |a 18F-FDG PET/CT reveals disease remission in a patient with ipilimumab-refractory advanced melanoma treated with pembrolizumab |
| 773 | 1 | 8 | |g volume:41 |g year:2016 |g number:2 |g pages:156-158 |g extent:3 |a 18F-FDG PET/CT reveals disease remission in a patient with ipilimumab-refractory advanced melanoma treated with pembrolizumab |
| 856 | 4 | 0 | |u https://doi.org/10.1097/RLU.0000000000001039 |x Resolving-System |x Verlag |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://journals.lww.com/nuclearmed/fulltext/2016/02000/18F_FDG_PET_CT_Reveals_Disease_Remission_in_a.13.aspx |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200507 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1076688373 |a Dimitrakopoulou-Strauss, Antonia |m 1076688373:Dimitrakopoulou-Strauss, Antonia |d 50000 |e 50000PD1076688373 |k 0/50000/ |p 3 |y j | ||
| 998 | |g 129790702 |a Hassel, Jessica C. |m 129790702:Hassel, Jessica C. |d 910000 |d 911300 |e 910000PH129790702 |e 911300PH129790702 |k 0/910000/ |k 1/910000/911300/ |p 2 | ||
| 998 | |g 1099707269 |a Sachpekidis, Christos |m 1099707269:Sachpekidis, Christos |d 50000 |e 50000PS1099707269 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN169765889X |e 3662243768 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1097/RLU.0000000000001039"],"eki":["169765889X"]},"physDesc":[{"extent":"3 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"CNM","title":"Clinical nuclear medicine","title_sort":"Clinical nuclear medicine"}],"language":["eng"],"note":["Gesehen am 17.10.05"],"disp":"18F-FDG PET/CT reveals disease remission in a patient with ipilimumab-refractory advanced melanoma treated with pembrolizumabClinical nuclear medicine","type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"issn":["1536-0229"],"zdb":["2045053-9"],"eki":["328186082"]},"part":{"text":"41(2016), 2, Seite 156-158","issue":"2","pages":"156-158","extent":"3","year":"2016","volume":"41"},"pubHistory":["1.1976 -"],"origin":[{"dateIssuedDisp":"1976-","publisher":"Lippincott Williams & Wilkins ; Ovid","publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1976"}],"recId":"328186082","titleAlt":[{"title":"CNM"}]}],"title":[{"title_sort":"18F-FDG PET/CT reveals disease remission in a patient with ipilimumab-refractory advanced melanoma treated with pembrolizumab","title":"18F-FDG PET/CT reveals disease remission in a patient with ipilimumab-refractory advanced melanoma treated with pembrolizumab"}],"person":[{"display":"Sachpekidis, Christos","role":"aut","family":"Sachpekidis","given":"Christos"},{"display":"Hassel, Jessica C.","role":"aut","family":"Hassel","given":"Jessica C."},{"display":"Dimitrakopoulou-Strauss, Antonia","role":"aut","family":"Dimitrakopoulou-Strauss","given":"Antonia"}],"language":["eng"],"origin":[{"dateIssuedDisp":"February 2016","dateIssuedKey":"2016"}],"recId":"169765889X","name":{"displayForm":["Christos Sachpekidis, Jessica C. Hassel, and Antonia Dimitrakopoulou-Strauss"]},"note":["Gesehen am 07.05.2020"]} | ||
| SRT | |a SACHPEKIDI18FFDGPETC2016 | ||